Biotech Innovator Morphogenesis, Inc. Launches Hi-Tech Digital Stock Offering to Fight Cancer (Yahoo! Sports)

UF startup Morphogenesis, Inc., a biotechnology company, plans to raise up to $20 million from the sale of its common stock to accredited investors. The company is not only embracing new securities industry rules, it is launching what it hopes to be a uniquely efficient capital raising process made possible by the confluence of social and technological changes.

Morphogenesis, a privately-held biotechnology company specializing in cell and gene therapies, has developed multi-indication immunotherapies which educates the patient’s own immune system to attack tumor cells throughout the body without damaging normal cells or tissues.

SharpSpring Integrates With PieSync to Provide Easy Two-Way Contact Syncing (EconoTimes)

UF startup SharpSpring, Inc., a global provider of cloud-based marketing technologies, announced the launch of its native integration with PieSync, a B2B connection service that allows users to perform two-way contact syncing between their favorite cloud apps in real time.

Using PieSync’s point-and-click interface, SharpSpring customers can build connections with dozens of other cloud-based platforms — such as Google Contacts, Zoho, Zendesk, Pipedrive, and SugarCRM — without the need for a developer. The automatic contact syncing feature eliminates the need for manual imports and exports, which helps reduce duplicate contacts and other errors.

AGTC Files Investigational New Drug Application for the Treatment of Achromatopsia (Yahoo! Finance)

UF startup Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, has filed an Investigational New Drug application (IND) with the U.S. Food and Drug Administration to conduct a Phase I/II clinical trial of the company’s gene therapy product candidate for the treatment of achromatopsia caused by mutations in the CNGA3 gene. AGTC previously initiated a Phase I/II clinical trial of its gene therapy product for the treatment of achromatopsia caused by mutations in the CNGB3 gene.

This program will be the fourth ophthalmic gene therapy candidate AGTC has advanced to human trials.

Sharklet’s Microtexture Earns FLEXcon Product of the Year Award (BusinessWire)

The 2016 Specialty Graphic Imaging Association recognized FLEXcon in its Product of the Year Competition for the company’s FLEXmark® V240 R Clear Sharklet finishing product. Sharklet™, designed by UF startup Sharklet Technologies, is the world’s first microtexture that inhibits microorganism attachment and growth. FLEXcon has mimicked the texture in an overlaminating film that is now available to the imaging market. The material features 2.4 mil vinyl coated with a permanent adhesive and backed with a polyester overlaminating liner.

The texture of shark skin makes it difficult for bacteria to attach and multiply. The texture of Sharklet™ textured film is similar, making it an environmentally-friendly approach to bacterial control. FLEXcon’s product limits the growth of bacteria on high-touch surfaces by covering graphics with Sharklet™.

Sun BioPharma Starts Fourth Cohort in Pancreatic Cancer Drug Trials (EconoTimes)

UF startup Sun BioPharma, Inc., a biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic diseases, announced that the Data Safety Monitoring Board has completed its safety review of the data from the dosing of the third cohort of patients. As a result of this positive review by the DSMB, Sun BioPharma has initiated the fourth patient cohort in the SBP-101 dose escalation phase of the study. The molecule has been shown to be highly effective in human pancreatic cancer models, demonstrating superior activity to existing FDA approved chemotherapy agents.

SharpSpring, Convrrt Partner to Turn Visitors into Sales (Digital Journal)

UF startup SharpSpring, Inc., a global provider of cloud-based marketing automation solutions, has partnered with Arizona start-up Convrrt, Inc. to accelerate the development of a next-generation landing page builder. This unique tool allows marketers to build web pages that capture leads using an intuitive interface that doesn’t require the user to write code. The user can simply choose a layout, update components, add a form and launch a landing page in minutes.

To accelerate the landing page builder’s latest feature enhancements, Convrrt partnered with SharpSpring’s development team to enhance its user interface and experience while also integrating the tool into the SharpSpring marketing automation platform.

Banyan Biomarkers Joins Quanterix to Address TBI (Business Report)

With this agreement, UF startup Banyan Biomarkers, Inc. and Quanterix Simoa will provide the tools and solutions necessary to support critical advancements in neurology research. Banyan Biomarkers is focused on developing a blood test that could be used by physicians and healthcare providers to rapidly and objectively detect the presence of mild and moderate traumatic brain injury (TBI) and improve the medical management of head injured patients. The Company’s test uses two brain specific protein biomarkers (Banyan UCH-L1™ and Banyan GFAP™) that rapidly appear in the blood after a brain injury.

Quanterix’ Simoa platform will incorporate the Banyan UCH-L1™ and Banyan GFAP™ assays to help further neurological research for improved TBI diagnosis and treatment.

Ark Applications and PAR Invest in Peerfit (Digital Journal)

Ark Applications, LLC and PAR, Inc. jointly announced a strategic investment in UF startup Peerfit, Inc., a provider of wellness experience personalization.

Peerfit utilizes a streamlined flexible platform tailored to the exploding wellness market. Its distinctive model allows enrolled members to customize their wellness experience by purchasing a monthly subscription that can be applied to various classes within their own city or in other markets at the best market rate.

Axogen’s Nerve Protector Enables Amputee to Move and Feel Prosthetic (The Doctors)

The national daytime talk show The Doctors presented the landmark surgical procedure involving the use of UF startup AxoGen’s AxoGuard® Nerve Protector. The segment featured an interview with Dr. Ajay K. Seth, an orthopedic surgeon at Spectrum Orthopedics in Canton, Ohio, and his patient, 44-year-old Melissa Loomis, whose arm was amputated above the elbow following a raccoon bite that became infected.

Seth reduced Loomis’ nerve pain and restored some nerve function to her arm by using Axogen’s AxoGuard® Nerve Protector to isolate and protect nerves, serving as a soft tissue graft.

Altavian Partners with College to Collect Data for NASA (Dayton Daily News)

UF startup Altavian Inc. is using its unmanned aerial systems in partnership with a Dayton, Ohio, community college to collect data for NASA engineers. Sinclair Community College and Altavian announced that the school would use the company’s fixed-wing Nova F7200 and its Galaxy R8700 octocopter, carrying a NASA sensor, to better understand the algae blooms that have plagued parts of Lake Erie for years.